A study led by researchers at the CUNY Institute for Implementation Science in Population Health (CUNY ISPH) at CUNY SPH reveals worrisome barriers to care for people who inject drugs in Puerto Rico.
Sep 28, 2023
0
0
A pediatric infectious disease team led by University at Buffalo faculty is screening and treating hepatitis C virus (HCV)-exposed infants. The clinic's efforts are documented in a new paper based on an 11-year retrospective ...
Jul 27, 2023
0
1
In the two decades since the opioid epidemic took off, the addiction crisis has claimed the lives of hundreds of thousands of Americans.
Jul 24, 2023
0
1
Use of strategies that require multiple visits to collect blood for hepatitis C virus (HCV) testing should be discontinued and replaced by single-visit sample collection, according to research published in the July 14 issue ...
Jul 14, 2023
0
0
A new USC study that zeros in on the workings of individual T cells targeting the hepatitis C virus (HCV) has revealed insights that could assist in the development of an effective vaccine.
Jun 27, 2023
0
2
Countries must intensify efforts to track HIV and hepatitis C virus (HCV) incidence among people who inject drugs, and to prioritize this group in prevention and elimination work, according to new University of Bristol-led ...
Mar 28, 2023
0
4
The importance of access to highly effective direct acting antiviral (DAA) treatments to help eliminate hepatitis C (HCV) among people living with HIV (PLHIV) has been demonstrated in new research led by Burnet Institute, ...
Jan 16, 2023
0
44
A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment ...
Dec 16, 2022
0
2
The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes approximately 400,000 deaths each ...
Nov 22, 2022
0
5
Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment, according to research published in the Aug. 9 early-release issue of the U.S. Centers for Disease Control ...
Aug 11, 2022
0
2
